Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998

Journal of Infectious Diseases

Volumn 186, Issue 7, 2002, Pages 1023-1027

  Louie, Janice K ^a   Chin Hsu, Ling ^b   Osmond, Dennis H ^a   Katz, Mitchell H ^b   Schwarcz, Sandra K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CAUSE OF DEATH; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PANCREATITIS; PRIORITY JOURNAL; SEPTICEMIA; UNITED STATES; VIRUS HEPATITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; CORONARY ARTERIOSCLEROSIS; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER DISEASES; LUNG DISEASES, OBSTRUCTIVE; MALE; NEOPLASMS; OVERDOSE; PANCREATITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SAN FRANCISCO; SEPSIS;

EID: 0036788675     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/343862     Document Type: Article

References (15)

1. Selik RM, Byers RH, Jr, Dworkin MS. Trends in diseases reported on US death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002;29:378-87.
2. Mocroft A, Brettle R, Kirk O, et al. Changes in cause of death across Europe [abstract 298]. In: 8th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Chicago). Alexandria, VA: Foundation for Retroviruses and Human Health, 2001.
3. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41(RR-17):1-19.
4. Schwarcz SK, Hsu LC, Parisi MK, Katz MH. The impact of the 1993 AIDS case definition on the completeness and timeliness of AIDS surveillance. AIDS 1999;13:1109-14.
5. National Center for Health Statistics. Mortality data from the National Vital Statistics System. In: Instruction manual part 2a, Instructions for classifying the underlying cause of death, ICD-9, and part 2b, Instructions for classifying the multiple causes of death, ICD-9. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, 1988.
6. Kim AY, Chung RT, Polsky B. Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy. AIDS Clin Rev 2000-01:263-306.
7. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000;283:74-80.
8. Prins M, Aguado IH, Brettle RP, et al. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injection drug users. AIDS 1997;11:1747-56.
9. Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000;132:369-72.
10. Niaura R, Shadel WG. HIV infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 2000;31:808-12.
11. Stall RD, Greenwood GL, Acree M, Paul J, Coates TJ. Cigarette smoking among gay and bisexual men. Am J Public Health 1999;89:1875-8.
12. + patients in the HAART era [abstract 696]. In: 9th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Seattle). Alexandria, VA: Foundation for Retroviruses and Human Health, 2002.
13. Holmberg SD, Moorman AC, Tong T, et al. Protease inhibitor drug use and myocardial infarction in ambulatory HIV-infected patients [abstract 941]. In: Proceedings of the 39th annual meeting of the Infectious Diseases Society of America (San Francisco). Alexandria, VA: Infectious Diseases Society of America, 2001.
14. Domanski MJ, Sloas MM, Follmann DA, et al. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr 1995;127:137-46.
15. Frippiat F, Derue G, Heller F, Honore P, Moreau M, Vandercam B. Acute pancreatitis associated with severe lactic acidosis in human immunodeficiency virus infected patients receiving triple therapy. J Antimicrob Chemother 2000;45:411-2.